Immuno-Oncology Drugs Market Size, Gross Margin Analysis, Development Status, Opportunities And Trends By Forecast 2032
As per the immuno-oncology drugs market report by The Business Research Company, the high cost of immuno-oncology therapies is a key factor hampering the growth of the market. The immunotherapy drugs cost more than other cancer drugs, and people who need immunotherapy for cancer, are often not able to afford it. High costs associated with drugs are a major issue faced by patients across the globe. In less wealthy countries, the lack of cost-effective drugs has influenced the health conditions of the population and led to a low average life expectancy.
The pressure to contain costs and demonstrate value is widespread.
The global immuno-oncology drugs market grew from $70.59 billion in 2022 to $81.46 billion in 2023 at a compound annual growth rate (CAGR) of 15.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The immuno-oncology drugs market is expected to grow from $136.15 billion in 2027 at a CAGR of 13.7%.
Read More On The Immuno-Oncology Drugs Market Report Here:
Major competitors in the immuno-oncology drugs market include Amgen Inc., AstraZeneca PLC., Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, and AbbVie Inc
The immuno-oncology drugs market is segmented -
By Type: Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Other Types
By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Prostate Cancer, Bladder Cancer, Other Therapeutic Applications
By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Check Out Buying Options For The Immuno-Oncology Drugs Market Report Here:
Immuno-oncology drugs refer to a therapy or cancer treatment that employs drugs to either boost or suppress the immune system in order to aid the body's defences against cancer, infection, and other disorders. It makes use of chemicals produced by the body or in a lab to strengthen the immune system and assist the body in locating and eliminating cancer cells.
The Table Of Content For The Immuno-oncology drugs market Include:
1. Executive Summary
2. Immuno-Oncology Drugs Market Characteristics
3. Immuno-Oncology Drugs Market Trends And Strategies
4. Immuno-Oncology Drugs Market - Macro Economic Scenario
5. Immuno-Oncology Drugs Market Size And Growth
27. Immuno-Oncology Drugs Market Competitive Landscape And Company Profiles
28. Immuno-Oncology Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market
30. Immuno-Oncology Drugs Market Future Outlook and Potential Analysis
The "Global Immuno-oncology drugs market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow Us On:
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immuno-Oncology Drugs Market Size, Gross Margin Analysis, Development Status, Opportunities And Trends By Forecast 2032 here
News-ID: 2873220 • Views: 253
More Releases from The Business research company
Argon Market Analysis: Promising Segments and Share Projections || Airgas, Air L …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company's Argon Global Market Report 2023 identifies the growing demand from the electronics industry is the major driver for the argon market's growth in the forecast period. As argon gas provides an inert atmosphere needed for rapid cooling and heating of materials, it will
Nanotechnology-Based Medical Devices Global Market is Expected to Grow $9.07 Bil …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company's Nanotechnology-Based Medical Devices Global Market Report 2023 identifies the increasing prevalence of chronic diseases is expected to propel the growth of the nanotechnology-based medical device market going forward. Chronic diseases are defined as problems that last for a year or longer and necessitate
Instrument Landing System And Visual Landing Aids Global Market $2.74 Billion By …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company's Instrument Landing System And Visual Landing Aids Global Market Report 2023 identifies the increasing air traffic is expected to propel the growth of the instrument landing system, and virtual landing aids market going forward. Air traffic refers to the number of aircraft flying
High Density Interconnect Global Market Worth $22.36 Billion at a CAGR of 10.4% …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company's High Density Interconnect Global Market Report 2023 identifies The increasing application of the automotive industry is expected to propel the growth of the high-density interconnect market going forward. The automotive industry is a sector that encompasses numerous organizations and firms involved in the
More Releases for Drugs
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.